Yufeng Jane Tseng Selected Research

1- benzyl- 2- (5- methyl- 2- furyl)benzimidazole

1/2016

A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yufeng Jane Tseng Research Topics

Disease

2	Infections 01/2022 - 09/2015
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 04/2018
1	Ischemia 06/2017
1	Tics (Tic) 06/2017
1	Hemorrhage 01/2016
1	Pulmonary Embolism 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Human Influenza (Influenza) 09/2015
1	Hypoxia (Hypoxemia) 05/2013
1	Neoplasm Metastasis (Metastasis) 05/2013

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	LipidsIBA 01/2022
1	CarbonIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Cell ExtractsIBA 06/2017
1	Oxygen (Dioxygen)IBA 06/2017
1	Glucose (Dextrose)FDA LinkGeneric 06/2017
1	1- benzyl- 2- (5- methyl- 2- furyl)benzimidazoleIBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2016
1	Viral ProteinsIBA 09/2015
1	RibonucleoproteinsIBA 09/2015
1	NucleoproteinsIBA 09/2015
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 09/2015
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 09/2015

Therapy/Procedure

2	Therapeutics 01/2022 - 05/2013
1	Quantum Dots (Quantum Dot) 01/2022
1	Resistance Training 04/2018